Performance of the Lumipulse plasma p‐tau217 assay to assess eligibility for amyloid‐lowering therapies
Lumipulse血浆p-tau217检测在评估患者是否适合接受淀粉样蛋白降低疗法方面的性能
期刊:Neuropsychopharmacology
影响因子:
doi:10.1038/s41386-022-01269-6
Ciampa, Claire J; Parent, Jourdan H; Harrison, Theresa M; Fain, Rebekah M; Betts, Matthew J; Maass, Anne; Winer, Joseph R; Baker, Suzanne L; Janabi, Mustafa; Furman, Daniella J; D'Esposito, Mark; Jagust, William J; Berry, Anne S; Algeciras‐Schimnich, Alicia; Ashrafzadeh‐Kian, Susan; Bornhorst, Joshua A; Figdore, Daniel; Burkett, Brian J; Cogswell, Petrice M; Johnson, Derek R; McCarter, Stuart J; Graff‐Radford, Jonathan; Petersen, Ronald; Ramanan, Vijay K